Adoption of organ-on-chip platforms by the pharmaceutical industry

Nature Reviews Drug Discovery, Published online: 13 October 2021; doi:10.1038/s41573-021-00323-0Adoption of organ-on-chip platforms by the pharmaceutical industry

3d

Adoption of organ-on-chip platforms by the pharmaceutical industry

3d

CRISPR technologies are going to need a bigger toolbox

Nature Reviews Drug Discovery, Published online: 12 October 2021; doi:10.1038/d41573-021-00177-6Feng Zhang discusses the expanding gene-editing toolkit, the need for better delivery systems and the reprogrammable biological technologies that remain to be discovered.

5d

FDA new drug approvals in Q3 2021

Nature Reviews Drug Discovery, Published online: 12 October 2021; doi:10.1038/d41573-021-00175-8FDA new drug approvals in Q3 2021

5d

CRISPR technologies are going to need a bigger toolbox

5d

FDA new drug approvals in Q3 2021

5d

mRNA flu shots move into trials

Nature Reviews Drug Discovery, Published online: 11 October 2021; doi:10.1038/d41573-021-00176-7COVID-19 provided an opportunity to show that mRNA vaccines can work. Now, drug companies are racing to apply the technology platform for influenza.

6d

mRNA flu shots move into trials

6d

Engineering living therapeutics with synthetic biology

Nature Reviews Drug Discovery, Published online: 06 October 2021; doi:10.1038/s41573-021-00285-3The design of cell-based therapeutics with synthetic biology is a rapidly growing strategy in medicine for the development of effective treatments for a variety of diseases. This article discusses advances in synthetic biology approaches to programme living...

2w

Engineering living therapeutics with synthetic biology

2w